Traders should monitor for potential downward pressure on TXG stock in the near term, especially if no offsetting buy-side catalysts emerge. The coordinated exit by top executives, including current CEO and CFO, raises questions about internal confidence ahead of upcoming earnings or strategic updates.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $18.89entry
- T+1 · 9mo ago +1.11%α +0.38% · $19.10
- T+5 · 9mo ago +22.50%α +21.88% · $23.14
- T+20 · 8mo ago +1.32%α +5.27% · $19.14
- T+60 · 6mo ago +13.55%α +5.30% · $21.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three corporate insiders at 10x Genomics, Inc. (TXG), including the CEO and CFO, sold shares in a coordinated open-market transaction on February 23, 2026, collectively disposing of 26,426 shares for approximately $490,900. The sales were executed at the same price, indicating a planned divestment, which may signal reduced confidence in near-term stock performance.
Key Financial Metrics
Key Facts
- CEO Serge Saxonov sold 9,632 shares for $178,928 in open-market transaction.
- CFO Adam Taich sold 8,968 shares for $166,593 in open-market transaction.
- Benjamin J. Hindson (former CEO, now listed as 'See Remarks') sold 7,826 shares for $145,379.
- All three sales occurred on the same day at identical price of $18.5764 per share.
- Total value of insider selling cluster: ~$490,900.
Financial Impact
$490,900 in insider selling over a single day
Risk Factors
- Insider selling can precede negative earnings surprises or guidance cuts.
- Concentration of sales among C-suite increases the perceived significance of the signal.
- No offsetting insider buying activity reported in the past 30 days.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TXG-1772103658792 |
Track record
28 reports on TXG
1 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers